IRS1 and lung carcinoma: In a previous study of stage I NSCLC, loss of IRS-1 expression was observed more frequently in SCC than other lung cancer types [23], similar to our observation that decreased IRS-1 expression is associated with poor survival outcomes in SCC but not ADC.